Magnesium Sulfate For Brain Injury

Completed · Phase 3

Conditions studied: Brain Injuries, Head Injury, Brain Concussion

In brief

The purpose of the study is to determine whether magnesium sulfate, given within 8 hours of a moderate or severe traumatic brain injury improves survival, decreases the number of people developing seizures, improves the survivors' mental and psychological functioning, including the ability to return to daily life, live independently, and return to work or school.

Key facts

Study ID

NCT00004730

Run by

University of Washington

Starts

1998-08-01

Expected to finish

2005-05-01

Last updated by the study team

2011-10-28

Who can join

Age: 14 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Traumatic brain injury with post-resuscitation Glasgow Coma Scale of 3-12 or, if intubated, motor score of 1-5, or who require emergent neurosurgical intervention precluding the accurate assessment of Glasgow Coma Scale.

You may not qualify if…

• Injury greater than 8 hours old
• Age under 14 years
• Compromised renal function (creatinine of 2.0 mb/dl or greater)
• Membership in a vulnerable population (e.g. pregnant woman, prisoner, etc.)
• Residence making follow-up unlikely (e.g. lives outside U.S.)
• Refusal to participate

Where it is running

• University of Washington — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.